IRDiRC’s Therapies Scientific Committee (TSC) would like to broaden the committee membership, to represent the worldwide rare diseases therapies community in […]
Read More
In the months of May and June 2022, the European Medicines Agency (EMA) recommended granting various forms of marketing authorisation […]
Read More
The ProDGNE consortium, funded as part of the EJP RD’s Joint Transnational Call 2020 “Pre-Clinical Research to Develop Effective Therapies […]
Read More